| __timestamp | Halozyme Therapeutics, Inc. | Taro Pharmaceutical Industries Ltd. |
|---|---|---|
| Wednesday, January 1, 2014 | 52602000 | 580006000 |
| Thursday, January 1, 2015 | 105812000 | 676585000 |
| Friday, January 1, 2016 | 113485000 | 778966000 |
| Sunday, January 1, 2017 | 285461000 | 671251000 |
| Monday, January 1, 2018 | 141726000 | 463508000 |
| Tuesday, January 1, 2019 | 150446000 | 445724000 |
| Wednesday, January 1, 2020 | 224227000 | 399725000 |
| Friday, January 1, 2021 | 361897000 | 296656000 |
| Saturday, January 1, 2022 | 520812000 | 293122000 |
| Sunday, January 1, 2023 | 636892000 | 268323000 |
| Monday, January 1, 2024 | 855907000 | 304979000 |
In pursuit of knowledge
In the competitive landscape of pharmaceuticals, understanding financial trends is crucial. This analysis highlights the gross profit trajectories of Halozyme Therapeutics, Inc. and Taro Pharmaceutical Industries Ltd. from 2014 to 2023. Over this period, Halozyme's gross profit surged by over 1,100%, peaking in 2023, while Taro experienced a 54% decline, reaching its lowest in the same year.
Halozyme's impressive growth, particularly from 2020 onwards, reflects its strategic advancements and market adaptability. By 2023, its gross profit reached approximately 636 million, showcasing a robust upward trend.
Conversely, Taro's gross profit saw a steady decline, dropping from its 2016 peak. This trend suggests potential challenges in market positioning or operational efficiency.
These insights underscore the dynamic nature of the pharmaceutical industry, where strategic decisions significantly impact financial outcomes.
Gross Profit Trends Compared: Merck & Co., Inc. vs Halozyme Therapeutics, Inc.
Gross Profit Analysis: Comparing Pfizer Inc. and Taro Pharmaceutical Industries Ltd.
Gross Profit Trends Compared: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
Vertex Pharmaceuticals Incorporated vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Gross Profit Trends Compared: Takeda Pharmaceutical Company Limited vs Halozyme Therapeutics, Inc.
Who Generates Higher Gross Profit? Dr. Reddy's Laboratories Limited or Halozyme Therapeutics, Inc.
Catalent, Inc. and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Walgreens Boots Alliance, Inc. vs Taro Pharmaceutical Industries Ltd.
Key Insights on Gross Profit: Halozyme Therapeutics, Inc. vs Alkermes plc
Halozyme Therapeutics, Inc. and Veracyte, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Grifols, S.A. or Taro Pharmaceutical Industries Ltd.
Key Insights on Gross Profit: MorphoSys AG vs Taro Pharmaceutical Industries Ltd.